June 2 (Reuters) - AstraZeneca Plc wouldconsider buying a company such as Juno Therapeutics Inc, Bloomberg reported AstraZeneca's CEO as saying,according to StreetInsider.
The companies were not immediately available to comment.
Juno is one among the few companies that are developing a newclass of immuno-oncology treatments called CAR-T cell therapies. (Reporting by Amrutha Penumudi in Bengaluru; Editing by TedKerr)